Search Results - "Pascher, A"

ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms by Delle Fave, G, O'Toole, D, Sundin, A, Taal, B, Ferolla, P, Ramage, J K, Ferone, D, Ito, T, Weber, W, Zheng-Pei, Z, De Herder, W W, Pascher, A, Ruszniewski, P

Get more information

ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms by Ramage, J K, De Herder, W W, Delle Fave, G, Ferolla, P, Ferone, D, Ito, T, Ruszniewski, P, Sundin, A, Weber, W, Zheng-Pei, Z, Taal, B, Pascher, A

Get more information

Transplantation for acute-on-chronic liver failure by Becker, F, Trebicka, J, Houben, P, Pascher, A

“…A review and discussion of the current literature on liver transplantation for acute-on-chronic liver failure (ACLF) was performed. The ACLF represents an…”
Get more information

Pancreatic Fistula and Biochemical Leak after Splenectomy: Incidence and Risk Factors—A Retrospective Single-Center Analysis by Mehdorn, A. S., Schwieters, A. K., Mardin, W. A., Senninger, N., Strücker, B., Pascher, A., Vowinkel, T., Becker, F.

“…Purpose Postoperative pancreatic fistula (POPF) is a complication discussed in the context of pancreatic surgery, but may also result from splenectomy; a…”
Get full text

Articular cartilage repair by genetically modified bone marrow aspirate in sheep by Ivkovic, A, Pascher, A, Hudetz, D, Maticic, D, Jelic, M, Dickinson, S, Loparic, M, Haspl, M, Windhager, R, Pecina, M

“…Bone marrow presents an attractive option for the treatment of articular cartilage defects as it is readily accessible, it contains mesenchymal progenitor…”
Get full text

A Randomized, Controlled Study to Assess the Conversion From Calcineurin‐Inhibitors to Everolimus After Liver Transplantation—PROTECT by Fischer, L., Klempnauer, J., Beckebaum, S., Metselaar, H. J., Neuhaus, P., Schemmer, P., Settmacher, U., Heyne, N., Clavien, P‐A., Muehlbacher, F., Morard, I., Wolters, H., Vogel, W., Becker, T., Sterneck, M., Lehner, F., Klein, C., Kazemier, G., Pascher, A., Schmidt, J., Rauchfuss, F., Schnitzbauer, A., Nadalin, S., Hack, M., Ladenburger, S., Schlitt, H. J.

“…Posttransplant immunosuppression with calcineurin inhibitors (CNIs) is associated with impaired renal function, while mTor inhibitors such as everolimus may…”
Get full text

European Society of Coloproctology consensus on the surgical management of intestinal failure in adults by Vaizey, C. J., Maeda, Y., Barbosa, E., Bozzetti, F., Calvo, J., Irtun, Ø., Jeppesen, P. B., Klek, S., Panisic-Sekeljic, M., Papaconstantinou, I., Pascher, A., Panis, Y., Wallace, W. D., Carlson, G., Boermeester, M.

“…Intestinal failure (IF) is a debilitating condition of inadequate nutrition due to an anatomical and/or physiological deficit of the intestine. Surgical…”
Get full text

Protein Kinase C Inhibitor Sotrastaurin in De Novo Liver Transplant Recipients: A Randomized Phase II Trial by Pascher, A., De Simone, P., Pratschke, J., Salamé, E., Pirenne, J., Isoneimi, H., Bijarnia, M., Krishnan, I., Klupp, J.

“…Efficacy and safety of protein kinase C inhibitor sotrastaurin (STN) with tacrolimus (TAC) was assessed in a 24‐month, multicenter, phase II study in de novo…”
Get full text

Everolimus and Early Calcineurin Inhibitor Withdrawal: 3‐Year Results From a Randomized Trial in Liver Transplantation by Sterneck, M., Kaiser, G. M., Heyne, N., Richter, N., Rauchfuss, F., Pascher, A., Schemmer, P., Fischer, L., Klein, C. G., Nadalin, S., Lehner, F., Settmacher, U., Neuhaus, P., Gotthardt, D., Loss, M., Ladenburger, S., Paulus, E. M., Mertens, M., Schlitt, H. J.

“…The feasibility of de novo everolimus without calcineurin inhibitor (CNI) therapy following liver transplantation was assessed in a multicenter, prospective,…”
Get full text

Gastric neuroendocrine neoplasias: manifestations and comparative outcomes by Felder, S, Jann, H, Arsenic, R, Denecke, T, Prasad, V, Knappe-Drzikova, B, Maasberg, S, Wiedenmann, B, Pavel, M, Pascher, A, Pape, U F

“…Although gastric neuroendocrine neoplasias (gNEN) are an orphan disease, their incidence is rising. The heterogeneous clinical course powers the ongoing…”
Get full text

ASO Visual Abstract: Radical Resection in Enteropancreatic Neuroendocrine Tumors—Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence by Merola, E., Pascher, A., Rinke, A., Bartsch, D. K., Zerbi, A., Nappo, G., Carnaghi, C., Ciola, M., McNamara, M. G., Zandee, W., Bertani, E., Marcucci, S., Modica, R., Grützmann, R., Fazio, N., de Herder, W., Valle, J. W., Gress, T. M., Delle Fave, G., de Pretis, G., Perren, A., Wiedenmann, B., Pavel, M. E.

Get full text

Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence by Merola, E., Pascher, A., Rinke, A., Bartsch, D. K., Zerbi, A., Nappo, G., Carnaghi, C., Ciola, M., McNamara, M. G., Zandee, W., Bertani, E., Marcucci, S., Modica, R., Grützmann, R., Fazio, N., de Herder, W., Valle, J. W., Gress, T. M., Fave, G. Delle, de Pretis, G., Perren, A., Wiedenmann, B., Pavel, M. E.

“…Background Surgery with radical intent is the only potentially curative option for entero-pancreatic neuroendocrine tumors (EP-NETs) but many patients develop…”
Get full text

Consensus on definition and severity grading of lymphatic complications after kidney transplantation by Mehrabi, A., Kulu, Y., Sabagh, M., Khajeh, E., Mohammadi, S., Ghamarnejad, O., Golriz, M., Morath, C., Bechstein, W. O., Berlakovich, G. A., Demartines, N., Duran, M., Fischer, L., Gürke, L., Klempnauer, J., Königsrainer, A., Lang, H., Neumann, U. P., Pascher, A., Paul, A., Pisarski, P., Pratschke, J., Schneeberger, S., Settmacher, U., Viebahn, R., Wirth, M., Wullich, B., Zeier, M., Büchler, M. W.

“…Background The incidence of lymphatic complications after kidney transplantation varies considerably in the literature. This is partly because a universally…”
Get full text

Sirolimus Conversion Regimen Versus Continued Calcineurin Inhibitors in Liver Allograft Recipients: A Randomized Trial by Abdelmalek, M. F., Humar, A., Stickel, F., Andreone, P., Pascher, A., Barroso, E., Neff, G. W., Ranjan, D., Toselli, L. T., Gane, E. J., Scarola, J., Goldberg‐Alberts, R., Maller, E. S., Lo, C.‐M.

“…A large prospective, open‐label, randomized trial evaluated conversion from calcineurin inhibitor (CNI)‐ to sirolimus (SRL)‐based immunosuppression for…”
Get full text

Brain Death Activates Donor Organs and Is Associated with a Worse I/R Injury After Liver Transplantation by Weiss, S., Kotsch, K., Francuski, M., Reutzel‐Selke, A., Mantouvalou, L, Klemz, R., Kuecuek, O., Jonas, S., Wesslau, C., Ulrich, F., Pascher, A., Volk, H‐D., Tullius, S. G., Neuhaus, P., Pratschke, J.

“…The majority of transplants are derived from donors who suffered from brain injury. There is evidence that brain death causes inflammatory changes in the…”
Get full text

Aberrant plasmacytoid dendritic cell distribution and function in patients with Crohn's disease and ulcerative colitis by Baumgart, D. C., Metzke, D., Guckelberger, O., Pascher, A., Grötzinger, C., Przesdzing, I., Dörffel, Y., Schmitz, J., Thomas, S.

“…Summary Dendritic cell (DC) function is believed to be of critical importance for the pathogenesis of inflammatory bowel disease (IBD). To date, most research…”
Get full text

SUN-P133: Malnutrition Screening of Gastroenterological Patients: The Relationship between Subjective Global Assesement, Bioelectrical Impedance Analysis and Surrogate Parameters by Knappe-Drzikova, B, Maasberg, S, Sturm, A, Pascher, A, Wiedenmann, B, Pape, U.-F

Get full text

PT06.6: Analysis of Treatment Results with Teduglutide on Intestinal Absorption and Nutritional Status in Patients with Short Bowel Syndrome by Pevny, S, Maasberg, S, Karber, M, Knappe-Drzikova, B, Thurmann, D, Gerlach, U.A, Müller, V.A, Pascher, A, Pape, U.-F

Get full text

Staff Satisfaction within Duty Hour Models: Longitudinal Survey on Suitability and Legal Conformity at a Surgical Maximum Care Department by Langelotz, C, Koplin, G, Pascher, A, Lohmann, R, Köhler, A, Pratschke, J, Haase, O

“…Between the conflicting requirements of clinic organisation, the European Working Time Directive, patient safety, an increasing lack of junior staff, and…”
Get more information

Tumor Necrosis Factor Alpha Inhibitors as Immunomodulatory Antirejection Agents after Intestinal Transplantation by Gerlach, U. A., Koch, M., Müller, H.‐P., Veltzke‐Schlieker, W., Neuhaus, P., Pascher, A.

“…We reported the successful administration of infliximab for late‐onset OKT3‐resistant rejection in two patients, who presented persistent ulcerative…”
Get full text